Safety Evaluation of Aminophylline and Methazolamide

Mountain Sickness Clinical Trial

Official title:
The Safety Evaluation of Aminophylline and Methazolamide When Administered Orally Alone and in Combination to Healthy Volunteers

Status Completed

Clinical Trial Summary

This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.

Clinical Trial Description

After successful completion of this safety trial, our goal will be to evaluate the safety of this combination in healthy individuals exposed to hypoxia and exercise. Subsequently, an efficacy study will clarify whether this drug combination improves physical and mental functions in human subjects under high altitude conditions. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01587027
Study type	Interventional
Source	Poudre Valley Health System
Contact
Status	Completed
Phase	Phase 1
Start date	December 2011
Completion date	February 2012

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT01182792` - Chronic Mountain Sickness, Systemic Vascular Function	N/A
Completed	`NCT00952302` - Study of the Effects of Iron Levels on the Lungs at High Altitude	N/A
Completed	`NCT04075565` - The Psychophysiological Effect of Simulated and Terrestrial Altitude	N/A
Completed	`NCT01187108` - Study of Cobalt's Role in Excessive Erythrocytosis Among High Altitude Dwellers in Cerro de Pasco, Peru	Phase 1/Phase 2
Not yet recruiting	`NCT06129825` - Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia
Completed	`NCT02463357` - Three New Ideas to Protect Special Forces From the Stress of High Altitude	Phase 4